-
2
-
-
26444495727
-
Effect of PhX A34, a new prostaglandin (PG) derivative, on intraocular pressure (IOP) after topical application to glaucomatous monkey eyes
-
Justin N, Wang RF, Camras CB, Stjernschantz J, Bito LZ, Podos SM. Effect of PhX A34, a new prostaglandin (PG) derivative, on intraocular pressure (IOP) after topical application to glaucomatous monkey eyes. Invest Ophthalmol Vis Sci. 1991;32(suppl):S947.
-
(1991)
Invest Ophthalmol Vis Sci.
, vol.32
, Issue.SUPPL.
-
-
Justin, N.1
Wang, R.F.2
Camras, C.B.3
Stjernschantz, J.4
Bito, L.Z.5
Podos, S.M.6
-
4
-
-
0002231615
-
Prostaglandins
-
Ritch R, Shields MB, Krupin T, eds. St Louis, Mo: Mosby-Year Book Inc
-
Camras CB. Prostaglandins. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. 2nd ed. St Louis, Mo: Mosby-Year Book Inc; 1995:1449-1461.
-
(1995)
The Glaucomas. 2nd Ed.
, pp. 1449-1461
-
-
Camras, C.B.1
-
5
-
-
0027418584
-
The potential of prostaglandin derivatives in glaucoma therapy
-
Alm A. The potential of prostaglandin derivatives in glaucoma therapy. Curr Opin Ophthalmol. 1993;4:44-50.
-
(1993)
Curr Opin Ophthalmol.
, vol.4
, pp. 44-50
-
-
Alm, A.1
-
6
-
-
0029206541
-
Mechanism of the prostaglandin-induced reduction of intraocular pressure in humans
-
Camras CB. Mechanism of the prostaglandin-induced reduction of intraocular pressure in humans. Adv Prostaglandin Thromboxane Leukot Res. 1995;23:519-525.
-
(1995)
Adv Prostaglandin Thromboxane Leukot Res.
, vol.23
, pp. 519-525
-
-
Camras, C.B.1
-
8
-
-
0023819463
-
2 on normal human intraocular pressure
-
published erratum appears in J Ocul Pharmacol. 1997;7:189
-
2 on normal human intraocular pressure [published erratum appears in J Ocul Pharmacol. 1997;7:189]. J Ocul Pharmacol. 1988;4:13-18.
-
(1988)
J Ocul Pharmacol.
, vol.4
, pp. 13-18
-
-
Flach, A.J.1
Eliason, J.A.2
-
10
-
-
0030906585
-
Effects of exogenous prostaglandins on aqueous humor dynamics and blood aqueous barrier function
-
Toris CB, Camras CB, Yablonski ME, Brubaker RF. Effects of exogenous prostaglandins on aqueous humor dynamics and blood aqueous barrier function. Surv Ophthalmol. 1997;41(suppl 2):S69-S75.
-
(1997)
Surv Ophthalmol.
, vol.41
, Issue.2 SUPPL.
-
-
Toris, C.B.1
Camras, C.B.2
Yablonski, M.E.3
Brubaker, R.F.4
-
12
-
-
0024425601
-
2α-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients
-
2α-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients. Ophthalmology. 1989;96:1329-1336.
-
(1989)
Ophthalmology
, vol.96
, pp. 1329-1336
-
-
Camras, C.B.1
Siebold, E.C.2
Lustgarten, J.S.3
-
13
-
-
0025950460
-
PhXA34, a new potent ocular hypotensive drug
-
Alm A, Villumsen J. PhXA34, a new potent ocular hypotensive drug. Arch Ophthalmol. 1991;109:1564-1568.
-
(1991)
Arch Ophthalmol.
, vol.109
, pp. 1564-1568
-
-
Alm, A.1
Villumsen, J.2
-
17
-
-
0025193619
-
2α on trabecular outflow facility in cynomolgus monkeys
-
2α on trabecular outflow facility in cynomolgus monkeys. Exp Eye Res. 1990;51:87-91.
-
(1990)
Exp Eye Res.
, vol.51
, pp. 87-91
-
-
Gabelt, B.T.1
Kaufman, P.L.2
|